{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:17:47Z","timestamp":1781288267611,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH080634"],"award-info":[{"award-number":["T32MH080634"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30MH058107"],"award-info":[{"award-number":["P30MH058107"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance (AMR) in <jats:italic>Neisseria gonorrhoeae<\/jats:italic> is an emerging global health threat. Surveillance of AMR in <jats:italic>N. gonorrhoeae<\/jats:italic> in the Western Pacific Region is important, as resistant strains have typically emerged from this region. There are sparse data regarding antibiotic susceptibility of <jats:italic>N. gonorrhoeae<\/jats:italic> from Vietnam. This study aimed to provide updated data on antibiotic susceptibilities in <jats:italic>N. gonorrhoeae<\/jats:italic> isolates from Hanoi, Vietnam.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2017 to 2019, 409\u2009<jats:italic>N. gonorrhoeae<\/jats:italic> clinical isolates were collected at the National Hospital for Venereology and Dermatology in Hanoi, Vietnam. Antibiotic susceptibility testing was performed by disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) protocol. The zone diameters of inhibition were recorded and interpreted according to standard CLSI criteria, except for azithromycin, due to the absence of CLSI interpretation. Categorical variables were analyzed by Chi-square and Fisher\u2019s exact tests. Linear regression was used to evaluate zones of inhibition by year.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 409 isolates, no isolates were susceptible to penicillin, 98.3% were resistant to ciprofloxacin, and all isolates were susceptible to spectinomycin. There were 122\/407 (30.0%) isolates resistant to azithromycin and there was an association between resistance and year (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.01), ranging from 15.3% of isolates in 2017 to 46.7% of the isolates in 2018. Resistance to cefixime was found in 13\/406 (3.2%) of isolates and there was no association by year (<jats:italic>p<\/jats:italic>\u2009=\u20090.30). Resistance to ceftriaxone occurred in 3\/408 (0.7%) of isolates. Linear regression indicated the zone of inhibition diameters decreased by 0.83\u2009mm each year for ceftriaxone (95% CI: \u2212\u20091.3, \u2212\u20090.4; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.01) and decreased by 0.83\u2009mm each year (95% CI: \u2212\u20091.33, \u2212\u20090.33; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.01) for azithromycin; the association was not significant for cefixime (<jats:italic>p<\/jats:italic>\u2009=\u20090.07).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found decreasing susceptibility of <jats:italic>N. gonorrhoeae<\/jats:italic> to ceftriaxone and azithromycin, as well as a high prevalence of resistance to azithromycin, among isolates in Hanoi, Vietnam from 2017 to 2019. The trends of decreasing susceptibility to first-line treatments are concerning and highlight the urgency of addressing antimicrobial resistance in <jats:italic>N. gonorrhoeae<\/jats:italic>. Expanded surveillance efforts within the Western Pacific Region are critical to monitoring trends and informing treatment guidelines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05532-3","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:04:00Z","timestamp":1604574240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017\u20132019"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-6458","authenticated-orcid":false,"given":"Paul C.","family":"Adamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Van Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Ha Long","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang Minh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Vu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"21","key":"5532_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1056\/nejmra1907194","volume":"382","author":"DA Williamson","year":"2020","unstructured":"Williamson DA, Chen MY. Emerging and reemerging sexually transmitted infections. N Engl J Med. 2020;382(21):2023\u201332. \n                  https:\/\/doi.org\/10.1056\/nejmra1907194\n                  \n                .","journal-title":"N Engl J Med"},{"issue":"3","key":"5532_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. \n                  https:\/\/doi.org\/10.1016\/s1473-3099(17)30753-3\n                  \n                .","journal-title":"Lancet Infect Dis"},{"key":"5532_CR3","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta; 2019. \n                  https:\/\/doi.org\/10.15620\/cdc:82532\n                  \n                .","DOI":"10.15620\/cdc:82532"},{"issue":"3","key":"5532_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/cmr.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587\u2013613. \n                  https:\/\/doi.org\/10.1128\/cmr.00010-14\n                  \n                .","journal-title":"Clin Microbiol Rev"},{"issue":"RR-03","key":"5532_CR5","first-page":"1","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1\u2013137 \n                  https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26042815\n                  \n                .","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"5532_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M, European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85\u201392. \n                  https:\/\/doi.org\/10.1177\/0956462412472837\n                  \n                .","journal-title":"Int J STD AIDS"},{"key":"5532_CR7","volume-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016. \n                  https:\/\/apps.who.int\/iris\/handle\/10665\/246114\n                  \n                ."},{"issue":"1","key":"5532_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0956462419886775","volume":"31","author":"H Fifer","year":"2020","unstructured":"Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS. 2020;31(1):4\u201315. \n                  https:\/\/doi.org\/10.1177\/0956462419886775\n                  \n                .","journal-title":"Int J STD AIDS"},{"key":"5532_CR9","volume-title":"Review of national treatment guidelines for sexually transmitted infections in the Western Pacific Region","author":"World Health Organization","year":"2018","unstructured":"World Health Organization: Review of national treatment guidelines for sexually transmitted infections in the Western Pacific Region. 2018. \n                  https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/14324\/WPR-2018-DCD-004-eng.pdf\n                  \n                ."},{"key":"5532_CR10","doi-asserted-by":"publisher","unstructured":"Jennison AV, Whiley D, Lahra MM, Graham RM, Cole MJ, Hughes G, Fifer H, Andersson M, Edwards A, Eyre D. Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018. Eurosurveillance. 2019;24(8). \n                  https:\/\/doi.org\/10.2807\/1560-7917.es.2019.24.8.1900118\n                  \n                .","DOI":"10.2807\/1560-7917.es.2019.24.8.1900118"},{"issue":"4","key":"5532_CR11","doi-asserted-by":"publisher","first-page":"e0213312","DOI":"10.1371\/journal.pone.0213312","volume":"14","author":"CRR George","year":"2019","unstructured":"George CRR, Enriquez RP, Gatus BJ, Whiley DM, Lo Y-R, Ishikawa N, Wi T, Lahra MM. Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016. PLoS One. 2019;14(4):e0213312. \n                  https:\/\/doi.org\/10.1371\/journal.pone.0213312\n                  \n                .","journal-title":"PLoS One"},{"issue":"6","key":"5532_CR12","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jac\/dkaa040","volume":"75","author":"PT Lan","year":"2020","unstructured":"Lan PT, Golparian D, Ringlander J, Van Hung L, Van Thuong N, Unemo M. Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015\u201316. J Antimicrob Chemother. 2020;75(6):1432\u20138. \n                  https:\/\/doi.org\/10.1093\/jac\/dkaa040\n                  \n                .","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5532_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2334-13-40","volume":"13","author":"B Olsen","year":"2013","unstructured":"Olsen B, Lan PT, Golparian D, Johansson E, Khang TH, Unemo M. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;13(1):40. \n                  https:\/\/doi.org\/10.1186\/1471-2334-13-40\n                  \n                .","journal-title":"BMC Infect Dis"},{"key":"5532_CR14","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 29th edition. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2019. \n                  http:\/\/www.clsi.org\/media\/1930\/m100ed28_sample.pdf\n                  \n                ."},{"key":"5532_CR15","unstructured":"Centers for Disease Control and Prevention. Gonorrhea laboratory information - antimicrobial resistance susceptibility testing. Atlanta; 2018. \n                  https:\/\/www.cdc.gov\/std\/gonorrhea\/lab\/diskdiff.htm\n                  \n                ."},{"issue":"6","key":"5532_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/jac\/dkp098","volume":"63","author":"M Unemo","year":"2009","unstructured":"Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009;63(6):1142\u201351. \n                  https:\/\/doi.org\/10.1093\/jac\/dkp098\n                  \n                .","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5532_CR17","doi-asserted-by":"publisher","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","volume":"14","author":"T Wi","year":"2017","unstructured":"Wi T, Lahra MM, Ndowa F, Bala M, Dillon J-AR, Ramon-Pardo P, Eremin SR, Bolan G, Unemo M. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 2017;14(7):e1002344. \n                  https:\/\/doi.org\/10.1371\/journal.pmed.1002344\n                  \n                .","journal-title":"PLoS Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05532-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T14:03:10Z","timestamp":1604844190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05532-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5532"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05532-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bacterial specimens were collected as part of routine surveillance activities. The analysis of de-identified specimens was not considered human subjects research. No administrative permission was needed to access the data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"809"}}